<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005147</url>
  </required_header>
  <id_info>
    <org_study_id>1018</org_study_id>
    <secondary_id>R01HL024489</secondary_id>
    <nct_id>NCT00005147</nct_id>
  </id_info>
  <brief_title>Epidemiology of Atherosclerosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To determine the role of genetic factors in predicting resistance and susceptibility to
      coronary artery disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Coronary artery disease appears to be a consequence of the interaction between an
      individual's genotype and exposure to environmental factors. Genetic information has the
      potential to contribute to the identification of families and individuals with a biological
      predisposition for developing coronary artery disease. Although numerous studies have
      suggested the possibility of a link between polymorphic genetic variation and coronary heart
      disease, it has not been possible to use any single genetic locus or combination of loci to
      establish a person's risk except for the case of familial hypercholesterolemia.

      Apolipoproteins play a critical role in regulating cellular uptake of lipoproteins by
      specific receptors, regulating the activities of lipoprotein lipase and lecithin-cholesterol
      acyl transferase, and in the indirect regulation of the intracellular enzymes,
      acyl-cholesterol acyl transferase and HMG Co-A reductase. This study provided insight into
      the role of environmental and genetic effects on phenotypic variation of the individual
      components of the molecules of lipid metabolism as well as on the relationships between
      components.

      Previous studies conducted under this grant include: the relationship between quantitative
      levels of apo A-I and coronary artery disease as defined by coronary angiography; the effects
      of exercise, alcohol, obesity, and pregnancy on apo A-I levels; the relationship between apo
      A-I and HDL levels in children and the mode of inheritance of apo A-I levels in pedigrees in
      the Rochester, Minnesota community; and characterization of the antigenic structure of
      apolipoproteins in coronary artery disease.

      DESIGN NARRATIVE:

      Subjects for the study were drawn from the Rochester Family Heart Study which initiated
      recruitment for the family study in January 1985. In 31 months of recruitment, 443 households
      were contacted and 300 agreed to participate. In August 1987 all individuals identified by
      these households had completed their clinic visits providing 1,999 physical exams. The 300
      households yielded 276 three and four generation pedigrees with 593 parents, 598
      grandparents, 14 great-grandparents, and 854 children. Disease information was obtained from
      medical records for an additional 400 grandparents. In 1988 an additional 2,100 individual
      members of 300 families were surveyed.

      Medical records and death certificates were reviewed to evaluate coronary artery disease
      endpoints in all adults members of the pedigrees. Clinical data collected included: a history
      of symptoms of coronary artery disease, arteriosclerosis obliterans, cerebrovascular disease
      or surgery for these diseases; smoking; medication; history of genetic relationships.
      Measurements were made of cholesterol, triglycerides, HDL and LDL cholesterol, apo A-I, apo
      A-II, apo E, apo C-III, apo C-II, apo B, apo Lp(a), LDL apo B, HDL apo E, and DNA extraction.
      Lipid, lipoprotein, and apolipoprotein phenotypes and the restriction fragment length
      polymorphisms (RFLP) were measured in candidate genes for coronary artery disease. Genetic
      and phenotype analyses were conducted at the University of Michigan. The RFLP and
      apolipoprotein isotyping analyses were conducted at the University of Pittsburgh. RFLP
      analysis and LDL receptor and A-I gene analysis were conducted at Charing Cross Medical
      Center in London, England.

      The study completion date listed in this record was obtained from the &quot;End Date&quot; entered in
      the Protocol Registration and Results System (PRS) record.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1979</start_date>
  <completion_date type="Actual">June 1991</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Atherosclerosis</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Coronary Arteriosclerosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Mailly F, Moll P, Kottke BA, Kamboh MI, Humphries SE, Ferrell RE. Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms. Genet Epidemiol. 1992;9(4):239-48.</citation>
    <PMID>1398044</PMID>
  </reference>
  <reference>
    <citation>Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet. 1991 Dec;49(6):1155-66. Erratum in: Am J Hum Genet 1992 Oct;51(4):942.</citation>
    <PMID>1842218</PMID>
  </reference>
  <reference>
    <citation>Kottke BA, Moll PP, Michels VV, Weidman WH. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc. 1991 Dec;66(12):1198-208.</citation>
    <PMID>1749288</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet. 1991 Nov;49(5):1063-74.</citation>
    <PMID>1928089</PMID>
  </reference>
  <reference>
    <citation>Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1330-48.</citation>
    <PMID>1911720</PMID>
  </reference>
  <reference>
    <citation>Turner ST, Michels VV. Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension. 1991 Aug;18(2):183-90.</citation>
    <PMID>1885226</PMID>
  </reference>
  <reference>
    <citation>Pérusse L, Moll PP, Sing CF. Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet. 1991 Jul;49(1):94-105.</citation>
    <PMID>2063879</PMID>
  </reference>
  <reference>
    <citation>Crews DE, Kamboh MI, Bindon JR, Ferrell RE. Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa. Am J Phys Anthropol. 1991 Feb;84(2):165-70.</citation>
    <PMID>2021192</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Weiss KM, Ferrell RE. Genetic studies of human apolipoproteins. XVI. APOE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico. Clin Genet. 1991 Jan;39(1):26-32.</citation>
    <PMID>1997212</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Ferrell RE. Genetic studies of human apolipoproteins. XV. An overview of IEF immunoblotting methods to screen apolipoprotein polymorphisms. Hum Hered. 1990;40(4):193-207. Review.</citation>
    <PMID>2199367</PMID>
  </reference>
  <reference>
    <citation>Ferrell RE, Kamboh MI, Majumder PP, Valdez R, Weiss KM. Genetic studies of human apolipoproteins. XIII. Quantitative polymorphism of apolipoprotein C-III in the Mayans of the Yucatán Peninsula. Hum Hered. 1990;40(3):127-35.</citation>
    <PMID>2365371</PMID>
  </reference>
  <reference>
    <citation>Eichner JE, Kuller LH, Ferrell RE, Meilahn EN, Kamboh MI. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Arteriosclerosis. 1990 May-Jun;10(3):379-85.</citation>
    <PMID>2344296</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Kelly LJ, Ferrell RE. Genetic studies of human apolipoproteins: XIV. A simple agarose isoelectric focusing gel method for apolipoprotein E phenotyping. Electrophoresis. 1990 Apr;11(4):314-8.</citation>
    <PMID>2340826</PMID>
  </reference>
  <reference>
    <citation>Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults. Hypertension. 1993 Oct;22(4):560-8.</citation>
    <PMID>8406661</PMID>
  </reference>
  <reference>
    <citation>Bren ND, Rastogi A, Kottke BA. Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays. Mayo Clin Proc. 1993 Jul;68(7):657-64.</citation>
    <PMID>8350639</PMID>
  </reference>
  <reference>
    <citation>Pettitt DJ, Moll PP, Knowler WC, Mott DM, Nelson RG, Saad MF, Bennett PH, Kottke BA. Insulinemia in children at low and high risk of NIDDM. Diabetes Care. 1993 Apr;16(4):608-15.</citation>
    <PMID>8462388</PMID>
  </reference>
  <reference>
    <citation>Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJ. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983 Aug 18;309(7):385-9.</citation>
    <PMID>6410239</PMID>
  </reference>
  <reference>
    <citation>Moll PP, Sing CF, Weidman WH, Gordon H, Ellefson RD, Hodgson PA, Kottke BA. Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives. Circulation. 1983 Jan;67(1):127-34.</citation>
    <PMID>6847791</PMID>
  </reference>
  <reference>
    <citation>Moll PP, Berry TD, Weidman WH, Ellefson R, Gordon H, Kottke BA. Detection of genetic heterogeneity among pedigrees through complex segregation analysis: an application to hypercholesterolemia. Am J Hum Genet. 1984 Jan;36(1):197-211.</citation>
    <PMID>6607671</PMID>
  </reference>
  <reference>
    <citation>Moll PP, Sing CF, Lussier-Cacan S, Davignon J. An application of a model for a genotype-dependent relationship between a concomitant (age) and a quantitative trait (LDL cholesterol) in pedigree data. Genet Epidemiol. 1984;1(4):301-14.</citation>
    <PMID>6544242</PMID>
  </reference>
  <reference>
    <citation>Kottke BA: The Role of Apolipoproteins A-I and A-II in Atherogenesis and Coronary Heart Disease: Clinical Measurements of Apolipoproteins. Perspect Lipid Disorders, 2:4-11, 1984</citation>
  </reference>
  <reference>
    <citation>Sing CF et al: Strategies for Elucidating the Phenotypic and Genetic Heterogeneity of a Chronic Disease with a Complex Etiology. In: Diseases of Complex Etiology in Small Populations: Ethnic Differences and Research Approaches, Chakraborty R, and Szathmary, JE (Eds) New York: Alan Liss, 39-66, 1985</citation>
  </reference>
  <reference>
    <citation>Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268-85.</citation>
    <PMID>3985008</PMID>
  </reference>
  <reference>
    <citation>Sing CF et al: Apolipoproteins and Cardiovascular Risk: Genetics and Epidemiology. Ann Biol Clin, 43:411-417, 1985</citation>
  </reference>
  <reference>
    <citation>Sing CF, Boerwinkle E, Turner ST. Genetics of primary hypertension. Clin Exp Hypertens A. 1986;8(4-5):623-51. Review.</citation>
    <PMID>3530548</PMID>
  </reference>
  <reference>
    <citation>Kottke BA: Perspectives in Medicine; Apolipoprotein Markers for Coronary Artery Diseases - A Dissenting View. Drug Ther, 16:151-171, 1986</citation>
  </reference>
  <reference>
    <citation>Boerwinkle E, Sing CF. Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet. 1986 Jul;39(1):137-44.</citation>
    <PMID>3463204</PMID>
  </reference>
  <reference>
    <citation>Moll PP, Sing CF, Williams RR, Mao SJ, Kottke BA. The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees. Am J Hum Genet. 1986 Mar;38(3):361-72.</citation>
    <PMID>3082191</PMID>
  </reference>
  <reference>
    <citation>Boehnke M, Moll PP, Lange K, Weidman WH, Kottke BA. Univariate and bivariate analyses of cholesterol and triglyceride levels in pedigrees. Am J Med Genet. 1986 Mar;23(3):775-92.</citation>
    <PMID>3953676</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet. 1986 May;50(Pt 2):181-94.</citation>
    <PMID>3435047</PMID>
  </reference>
  <reference>
    <citation>Kottke BA, Zinsmeister AR, Holmes DR Jr, Kneller RW, Hallaway BJ, Mao SJ. Apolipoproteins and coronary artery disease. Mayo Clin Proc. 1986 May;61(5):313-20.</citation>
    <PMID>3702492</PMID>
  </reference>
  <reference>
    <citation>Hurt RD, Briones ER, Offord KP, Patton JG, Mao SJ, Morse RM, Kottke BA. Plasma lipids and apolipoprotein A-I and A-II levels in alcoholic patients. Am J Clin Nutr. 1986 Apr;43(4):521-9.</citation>
    <PMID>3962905</PMID>
  </reference>
  <reference>
    <citation>Badimon JJ, Kottke BA, Chen TC, Chan L, Mao SJ. Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis. Atherosclerosis. 1986 Jul;61(1):57-66.</citation>
    <PMID>3730054</PMID>
  </reference>
  <reference>
    <citation>Au YP, Hallaway BJ, Kottke BA. Use of a quality-control plasma sample to decrease interassay variation in radioimmunoassays of apolipoprotein A-I. Clin Chem. 1986 Jul;32(7):1394-7.</citation>
    <PMID>3087660</PMID>
  </reference>
  <reference>
    <citation>Au YP, Bren ND, Kottke BA. A rapid apolipoprotein E radioimmunoassay using solid-phase staphylococcus protein. Use of pooled plasma as a secondary standard. Biochem Biophys Res Commun. 1986 Jul 16;138(1):455-62.</citation>
    <PMID>3091017</PMID>
  </reference>
  <reference>
    <citation>Kottke BA: Hyperlipoproteinemia. The Case for Individualized Care. Consultant, 26:160-169, 1986</citation>
  </reference>
  <reference>
    <citation>Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet. 1987 Jul;27(3):567-82.</citation>
    <PMID>3631131</PMID>
  </reference>
  <reference>
    <citation>Templeton AR, Boerwinkle E, Sing CF. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics. 1987 Oct;117(2):343-51.</citation>
    <PMID>2822535</PMID>
  </reference>
  <reference>
    <citation>Boerwinkle E, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet. 1987 Jul;51(Pt 3):211-26.</citation>
    <PMID>3688836</PMID>
  </reference>
  <reference>
    <citation>Sing CF, Boerwinkle EA. Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. Ciba Found Symp. 1987;130:99-127. Review.</citation>
    <PMID>3327665</PMID>
  </reference>
  <reference>
    <citation>Boehnke M, Moll PP, Kottke BA, Weidman WH. Partitioning the variability of fasting plasma glucose levels in pedigrees. Genetic and environmental factors. Am J Epidemiol. 1987 Apr;125(4):679-89.</citation>
    <PMID>3826046</PMID>
  </reference>
  <reference>
    <citation>Sing CF et al: Characterization of Genes Affecting Quantitative Traits in Humans. Proceedings Second International Conference on Quantitative Genetics, B. Weir (Ed.) Sinauer. In press, 1987</citation>
  </reference>
  <reference>
    <citation>Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1-21. Review.</citation>
    <PMID>3277611</PMID>
  </reference>
  <reference>
    <citation>Lavie CJ, Gau GT, Squires RW, Kottke BA. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc. 1988 Jun;63(6):605-21. Review.</citation>
    <PMID>3287024</PMID>
  </reference>
  <reference>
    <citation>Moll PP, Michels VV, Weidman WH, Kottke BA. Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet. 1989 Jan;44(1):124-39.</citation>
    <PMID>2491774</PMID>
  </reference>
  <reference>
    <citation>Kaprio J, Ferrell RE, Kottke BA, Sing CF. Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin Genet. 1989 Oct;36(4):266-8.</citation>
    <PMID>2509115</PMID>
  </reference>
  <reference>
    <citation>Boehnke M, Moll PP. Identifying pedigrees segregating at a major locus for a quantitative trait: an efficient strategy for linkage analysis. Am J Hum Genet. 1989 Feb;44(2):216-24.</citation>
    <PMID>2912068</PMID>
  </reference>
  <reference>
    <citation>Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL, Fuller T, Sing CF. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension. 1989 Apr;13(4):378-91.</citation>
    <PMID>2925236</PMID>
  </reference>
  <reference>
    <citation>Hasstedt SJ, Moll PP. Estimation of genetic model parameters: variables correlated with a quantitative phenotype exhibiting major locus inheritance. Genet Epidemiol. 1989;6(2):319-32.</citation>
    <PMID>2721927</PMID>
  </reference>
  <reference>
    <citation>Carlson TL, Kottke BA. Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells. Biochem J. 1989 Nov 15;264(1):241-7.</citation>
    <PMID>2513806</PMID>
  </reference>
  <reference>
    <citation>Kottke BA, Friedlaender JS, Zerba KE, Sing CF. Lipid and apolipoprotein levels in six Solomon Island societies differ from those in a U.S. white population. Am J Phys Anthropol. 1990 Apr;81(4):483-91.</citation>
    <PMID>2110417</PMID>
  </reference>
  <reference>
    <citation>Reilly SL, Kottke BA, Sing CF. The effects of generation and gender on the joint distributions of lipid and apolipoprotein phenotypes in the population at large. J Clin Epidemiol. 1990;43(9):921-40.</citation>
    <PMID>2213081</PMID>
  </reference>
  <reference>
    <citation>Sing CF, Haviland MB, Zerba KE, Templeton AR. Application of cladistics to the analysis of genotype-phenotype relationships. Eur J Epidemiol. 1992 May;8 Suppl 1:3-9.</citation>
    <PMID>1354623</PMID>
  </reference>
  <reference>
    <citation>Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet. 1992 Dec;51(6):1311-24.</citation>
    <PMID>1463013</PMID>
  </reference>
  <reference>
    <citation>Hallaway BJ, Rastogi A, Kottke BA. Apolipoprotein B quantified by particle-concentration fluorescence immunoassay. Clin Chem. 1992 Dec;38(12):2387-91.</citation>
    <PMID>1458572</PMID>
  </reference>
  <reference>
    <citation>Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in Caucasians 47 to 89 years old. Hypertension. 1992 Dec;20(6):841-50.</citation>
    <PMID>1452301</PMID>
  </reference>
  <reference>
    <citation>Sing CF, Moll PP. Genetics of atherosclerosis. Annu Rev Genet. 1990;24:171-87. Review.</citation>
    <PMID>2088166</PMID>
  </reference>
  <verification_date>April 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>May 12, 2016</last_update_submitted>
  <last_update_submitted_qc>May 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

